HAE international home therapy consensus document

Area of Science:

• Immunology
• Genetics
• Pharmacology

Background:

• Hereditary angioedema (HAE), a C1 inhibitor deficiency, causes debilitating and potentially fatal swelling attacks.
• Current treatments require medical facility visits, leading to delays in care.
• Early intervention is crucial for effective management of HAE attacks.

Purpose of the Study:

• To review evidence supporting patient-controlled home treatment for acute HAE attacks.
• To propose a framework for implementing home or self-administration programs for HAE patients.
• To enhance symptom control and improve patient quality of life through accessible therapies.

Main Methods:

• Literature review of existing studies on home therapy for HAE.
• Analysis of the benefits and challenges of self or assisted administration.
• Development of a proposed framework for patient and physician engagement in home treatment programs.

Main Results:

• Home therapy facilitates earlier administration of treatments for HAE attacks.
• Patient-controlled administration can lead to better symptom control and reduced attack severity.
• Evidence supports the feasibility and benefits of home-based HAE management.

Conclusions:

• Home therapy for HAE is a viable option for improving patient outcomes.
• Self or assisted administration empowers patients, enhancing their quality of life.
• A structured framework is needed to guide the safe and effective implementation of HAE home treatment programs.